Tonia Aristotelous
About Tonia Aristotelous
Tonia Aristotelous is a Research Scientist I at the Broad Institute of MIT and Harvard, specializing in cancer research and drug discovery. She has a diverse background in both academic and industrial settings, with experience in protein-ligand interaction measurements.
Current Role at Broad Institute
Tonia Aristotelous serves as a Research Scientist I at the Broad Institute of MIT and Harvard. She has held this position since 2020, contributing to cancer research and drug discovery initiatives. Her work involves applying her expertise in protein-ligand interaction measurements, particularly utilizing Surface Plasmon Resonance techniques. This role allows her to engage in significant research projects aimed at advancing therapeutic strategies.
Previous Experience in Drug Discovery
Before her current role, Tonia Aristotelous worked at Kinetic Discovery Ltd as a Consultant from 2012 to 2013 in Dundee, United Kingdom. She also served as a Postdoctoral Research Fellow at the University of Hertfordshire from 2018 to 2020. Her earlier experiences include a part-time Research Assistant position and an Undergraduate Student Project at the University of Dundee, where she focused on biological chemistry and drug discovery.
Educational Background
Tonia Aristotelous completed her PhD studies at the University of Dundee, where she focused on Life Sciences from 2012 to 2017. She also achieved a Doctor of Philosophy degree during this period. Prior to her doctoral studies, she earned a BSc Honours in Biomolecular Drug Discovery from the University of Dundee from 2007 to 2011. Her academic training has provided a strong foundation for her research in drug discovery.
Research Focus and Expertise
Tonia Aristotelous has developed expertise in protein-ligand interaction measurements, particularly through the use of Surface Plasmon Resonance. Her current research focus is on cancer, where she applies her knowledge to drug discovery efforts. She has been involved in both academic and industrial collaborations, enhancing her contributions to the field.